Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.
about
Slow-release oral morphine as maintenance therapy for opioid dependenceQTc interval screening for cardiac risk in methadone treatment of opioid dependenceSlow-release oral morphine as maintenance therapy for opioid dependenceECG screening for preventing long QTc-related cardiac morbidity/mortality in methadone treated opioid addictsPharmacological treatment for depression during opioid agonist treatment for opioid dependenceOpioid overdose prevention and naloxone rescue kits: what we know and what we don't knowOpioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysisDrugs-Related Death Soon after Hospital-Discharge among Drug Treatment Clients in Scotland: Record Linkage, Validation, and Investigation of Risk-FactorsSurvival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatmentMortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studiesRisk factors for recent nonfatal overdose among HIV-infected Russians who inject drugs.Associations among pain, non-medical prescription opioid use, and drug overdose history.Incarceration and opioid withdrawal: the experiences of methadone patients and out-of-treatment heroin users.Developing an electronic health record (EHR) for methadone treatment recording and decision support.Opioid dependence treatment: options in pharmacotherapy.Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research DatabaseExamining non-AIDS mortality among people who inject drugs.Coverage of overdose prevention programs for opiate users and injectors: a cross-sectional studyIs residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder.National record linkage study of mortality for a large cohort of opioid users ascertained by drug treatment or criminal justice sources in England, 2005-2009.Changes in somatic disease incidents during opioid maintenance treatment: results from a Norwegian cohort study.Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10.High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study.A follow-up study of heroin addicts (VEdeTTE2): study design and protocolAssociation of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug usersHIV infection and risk of overdose: a systematic review and meta-analysisImpact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-AnalysisMortality among people who inject drugs: a systematic review and meta-analysis.Diversity in causes and characteristics of drug-induced deaths in an urban setting.Community correctional agents' views of medication-assisted treatment: Examining their influence on treatment referrals and community supervision practices.Injecting drug users in Scotland, 2006: Listing, number, demography, and opiate-related death-ratesTake-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial.Interim methadone treatment: impact on arrests.Psychosocial and contextual correlates of opioid overdose risk among drug users in St. Petersburg, RussiaOpioid overdose and naloxone education in a substance use disorder treatment program.Evaluating the impact of a national naloxone programme on ambulance attendance at overdose incidents: a controlled time-series analysis.Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine.Association between process measures and mortality in individuals with opioid use disorders.Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs.Fatal and non-fatal overdose after narcology hospital discharge among Russians living with HIV/AIDS who inject drugs.
P2860
Q24198233-CA601915-1394-4B67-A9A6-7ACC17922D8AQ24201880-17FF5E4E-8642-4701-A1D8-144FAD7631FDQ24202258-7093971E-A65C-41AC-9576-A3E09A9C3EBCQ24235379-83E3FC9E-F5F9-43F3-913F-A83C485C0841Q24235458-C8CDB63A-30ED-42B6-8883-8745E1E9C3AEQ28365114-45189A95-44CA-407A-A83B-E1FB9591ED12Q28397248-8B140D8C-1A90-4A21-9E29-318CCD58E9ACQ28550704-6111E15B-9AA0-487A-9331-4C530FCB004AQ28750627-DC97456C-E7D7-4DF1-ACF2-AFB7275BF373Q30234647-9B520964-907D-4269-8D70-D5143F7ACEB1Q33691974-80EEF3DC-F1B4-47E5-9CC8-1A198ADD0CAEQ33724605-CF228BE9-98D4-4F9C-88E7-48FC9A2B90FEQ33727237-3F4F4743-B834-40E2-9018-CB5675CB8057Q33809928-3C45D146-9703-4CC2-8491-EB1E214379EFQ33868638-6F069392-BF57-4F8A-A589-A5D8B71075B0Q34246166-652E3522-612F-4FDC-8466-324F6595427EQ34585154-A9A24EBA-F185-457D-BAE5-2DFB65431886Q34587153-987FE2B6-ABCD-4A7A-A738-A2F8C704AE4BQ34620651-2999E22E-BF7D-43B9-8FB7-48B4066283EEQ34959778-69B23E6E-6B23-4A40-A3C4-5E5D0CCE7AF7Q35320110-7E56B33F-24A9-43DD-8A00-65CCF565867EQ35674032-EE4682B3-99C0-43AA-AE16-9820D5D3BBECQ35674947-FC700A4E-BD57-41F9-9F28-03359397F449Q35723219-9C992FAB-B990-4C88-B560-8BE8582AAFB0Q35864200-9963DB94-AF17-4E19-A4CD-07A8997530F9Q35898498-4BC9B2F6-A14E-4F1D-B44E-AC6F98B5E04EQ36061620-C38031F7-22AF-4EF7-B55E-583616CD8C71Q36706977-BF845CC4-89D9-4C61-89EB-D852B6FD30B3Q36752993-B06D4B0D-F745-4B3E-B553-89D07096DB7FQ36774534-1A1CBA74-DE82-4A6C-B67D-2773DBCF792CQ36879835-EA11C284-C445-4BB9-9CD7-258F723E6334Q37225942-08F7C748-A885-47AC-99ED-798ADB2B48EBQ37234887-EC22CA2F-02D4-41CC-9E2B-8D9965CF8C27Q37299196-3356C6E1-F106-4746-A4D3-3BE834716D17Q37352258-58C690BD-514A-4F6F-9B3E-126FD0D0348DQ37595941-817582BC-E6B1-446F-9608-D9493A612BCDQ38695672-0280DA89-D5C6-4681-BCA9-596FD2F8FC57Q38701857-638D122D-E22C-4AA2-947A-DC544ADFE950Q38931214-736EE773-6AD8-4BE2-8313-A5B8B8E166F9Q39138996-4504B428-A7EE-446D-AB7F-1DA785022B06
P2860
Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Risk of fatal overdose during ...... site prospective cohort study.
@en
Risk of fatal overdose during ...... site prospective cohort study.
@nl
type
label
Risk of fatal overdose during ...... site prospective cohort study.
@en
Risk of fatal overdose during ...... site prospective cohort study.
@nl
prefLabel
Risk of fatal overdose during ...... site prospective cohort study.
@en
Risk of fatal overdose during ...... site prospective cohort study.
@nl
P2093
P2860
P50
P1433
P1476
Risk of fatal overdose during ...... site prospective cohort study.
@en
P2093
Carlo A Perucci
Fabrizio Faggiano
Giuseppe Salamina
Roberto Diecidue
VEdeTTE Study Group
P2860
P304
P356
10.1111/J.1360-0443.2007.02025.X
P407
P50
P577
2007-12-01T00:00:00Z